South-East Asia (WHO region) vs Palestine, State of: Pneumococcal conjugate second or third-dose vaccines (PCVc)

South-East Asia (WHO region)
92.0%
in 2025
Palestine, State of
99.0%
in 2025
South-East Asia (WHO region) rank
1st
Palestine, State of rank
1st

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • South-East Asia (WHO region)
  • Palestine, State of
020406080100200820162025

How they compare

Palestine, State of currently reports 99.0% against 92.0% in South-East Asia (WHO region), a difference of 7.0%.

That makes Palestine, State of's figure about 1.1 times South-East Asia (WHO region)'s.

Across all 18 years both countries report, Palestine, State of has been ahead every year.

South-East Asia (WHO region) ranks 1st and Palestine, State of ranks 1st of 11 groups.

Palestine, State of has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade South-East Asia (WHO region) Palestine, State of Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 7.8% 71.3% 63.5% Palestine, State of
2020s 66.0% 96.2% 30.2% Palestine, State of

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), South-East Asia (WHO region) or Palestine, State of?
Palestine, State of, at 99.0% against 92.0% in South-East Asia (WHO region) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between South-East Asia (WHO region) and Palestine, State of?
7.0%, with Palestine, State of ahead.
How many years of comparable data are there for South-East Asia (WHO region) and Palestine, State of?
18 years are reported by both, from 2008 to 2025.
How do South-East Asia (WHO region) and Palestine, State of rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
South-East Asia (WHO region) ranks 1st and Palestine, State of ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South-East Asia (WHO region) vs Palestine, State of: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 14 September 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/south-east-asia-who-region/west-bank-and-gaza/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/south-east-asia-who-region/west-bank-and-gaza/">South-East Asia (WHO region) vs Palestine, State of: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed